Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report.

Journal of medical case reports

Bender Ignacio RA, Liu AY, Sohani AR, Vyas JM.
PMID: 20370895
J Med Case Rep. 2010 Apr 06;4:102. doi: 10.1186/1752-1947-4-102.

INTRODUCTION: Infection and malignancy often have common characteristics which render the differential diagnosis for a prolonged fever difficult. Imaging and tissue biopsy are crucial in making a correct diagnosis, though differentiating between chronic osteomyelitis and malignancy is not always...

Cite
Bender Ignacio RA, Liu AY, Sohani AR, et al. Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report. J Med Case Rep. 2010;4:102doi: 10.1186/1752-1947-4-102.
Bender Ignacio, R. A., Liu, A. Y., Sohani, A. R., & Vyas, J. M. (2010). Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report. Journal of medical case reports, 4102. https://doi.org/10.1186/1752-1947-4-102
Bender Ignacio, Rachel A, et al. "Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report." Journal of medical case reports vol. 4 (2010): 102. doi: https://doi.org/10.1186/1752-1947-4-102
Bender Ignacio RA, Liu AY, Sohani AR, Vyas JM. Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report. J Med Case Rep. 2010 Apr 06;4:102. doi: 10.1186/1752-1947-4-102. PMID: 20370895; PMCID: PMC2907869.
Copy Download .nbib Format: NLM
Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting.

AIDS research and therapy

Bender Ignacio RA, Chu J, Power MC, Douaiher J, Lane JD, Collins JP, Stone VE.
PMID: 25120579
AIDS Res Ther. 2014 Aug 04;11:24. doi: 10.1186/1742-6405-11-24. eCollection 2014.

INTRODUCTION: Despite recommendations by the Centers for Disease Control (CDC) that all adults be offered non-targeted HIV screening in all care settings, screening in acute-care settings remains unacceptably low. We performed an observational study to evaluate an HIV screening...

Cite
Bender Ignacio RA, Chu J, Power MC, et al. Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting. AIDS Res Ther. 2014;11:24doi: 10.1186/1742-6405-11-24.
Bender Ignacio, R. A., Chu, J., Power, M. C., Douaiher, J., Lane, J. D., Collins, J. P., & Stone, V. E. (2014). Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting. AIDS research and therapy, 1124. https://doi.org/10.1186/1742-6405-11-24
Bender Ignacio, Rachel A, et al. "Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting." AIDS research and therapy vol. 11 (2014): 24. doi: https://doi.org/10.1186/1742-6405-11-24
Bender Ignacio RA, Chu J, Power MC, Douaiher J, Lane JD, Collins JP, Stone VE. Influence of providers and nurses on completion of non-targeted HIV screening in an urgent care setting. AIDS Res Ther. 2014 Aug 04;11:24. doi: 10.1186/1742-6405-11-24. eCollection 2014. PMID: 25120579; PMCID: PMC4130435.
Copy Download .nbib Format: NLM
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.

medRxiv : the preprint server for health sciences

Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM.
PMID: 34704092
medRxiv. 2021 Oct 18; doi: 10.1101/2021.10.15.21265063.

BACKGROUND: Understanding the spectrum of SARS-CoV-2 infection and COVID-19 disease in people with HIV (PWH) is critical to provide clinical guidance and implement risk-reduction strategies.OBJECTIVE: To characterize COVID-19 in PWH in the United States and identify predictors of disease...

Cite
Shapiro AE, Bender Ignacio RA, Whitney BM, et al. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv. 2021;doi: 10.1101/2021.10.15.21265063.
Shapiro, A. E., Bender Ignacio, R. A., Whitney, B. M., Delaney, J. A., Nance, R. M., Bamford, L., Wooten, D., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Webel, A. R., Kim, H. N., Van Rompaey, S. E., Christopoulos, K., Jacobson, J., Karris, M., Smith, D., Johnson, M. O., Willig, A., Eron, J. J., Hunt, P., Moore, R. D., Saag, M. S., Mathews, W. C., Crane, H. M., Cachay, E. R., Kitahata, M. M. (2021). Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.10.15.21265063
Shapiro, Adrienne E, et al. "Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.10.15.21265063
Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv. 2021 Oct 18; doi: 10.1101/2021.10.15.21265063. PMID: 34704092; PMCID: PMC8547524.
Copy Download .nbib Format: NLM
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

medRxiv : the preprint server for health sciences

Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E.
PMID: 34909782
medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296.

OBJECTIVES: To define the incidence of clinically-detected COVID-19 in people with HIV (PWH) in the US and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.DESIGN: Observational study within the CFAR Network of...

Cite
Bender Ignacio RA, Shapiro AE, Nance RM, et al. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021;doi: 10.1101/2021.12.07.21267296.
Bender Ignacio, R. A., Shapiro, A. E., Nance, R. M., Whitney, B. M., Delaney, J., Bamford, L., Wooten, D., Karris, M., Mathews, W. C., Kim, H. N., Van Rompaey, S. E., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Jacobson, J., Saag, M. S., Moore, R. D., Eron, J. J., Willig, A. L., Christopoulos, K. A., Martin, J., Hunt, P. W., Crane, H. M., Kitahata, M. M., Cachay, E. (2021). Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio, R A, et al. "Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296. PMID: 34909782; PMCID: PMC8669849.
Copy Download .nbib Format: NLM
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.

medRxiv : the preprint server for health sciences

Ogimi C, Qu P, Boeckh M, Bender Ignacio RA, Zangeneh SZ.
PMID: 33106815
medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.17.20214510.

We investigated whether countries with higher coverage of childhood live vaccines [BCG or measles-containing-vaccine (MCV)] have reduced risk of COVID-19 related mortality, accounting for known systems differences between countries. In this ecological study of 140 countries using publicly available...

Cite
Ogimi C, Qu P, Boeckh M, et al. Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv. 2020;doi: 10.1101/2020.10.17.20214510.
Ogimi, C., Qu, P., Boeckh, M., Bender Ignacio, R. A., & Zangeneh, S. Z. (2020). Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.10.17.20214510
Ogimi, Chikara, et al. "Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.10.17.20214510
Ogimi C, Qu P, Boeckh M, Bender Ignacio RA, Zangeneh SZ. Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.17.20214510. PMID: 33106815; PMCID: PMC7587835.
Copy Download .nbib Format: NLM
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

medRxiv : the preprint server for health sciences

Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E.
PMID: 34909782
medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296.

OBJECTIVES: To define the incidence of clinically-detected COVID-19 in people with HIV (PWH) in the US and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.DESIGN: Observational study within the CFAR Network of...

Cite
Bender Ignacio RA, Shapiro AE, Nance RM, et al. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021;doi: 10.1101/2021.12.07.21267296.
Bender Ignacio, R. A., Shapiro, A. E., Nance, R. M., Whitney, B. M., Delaney, J., Bamford, L., Wooten, D., Karris, M., Mathews, W. C., Kim, H. N., Van Rompaey, S. E., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Jacobson, J., Saag, M. S., Moore, R. D., Eron, J. J., Willig, A. L., Christopoulos, K. A., Martin, J., Hunt, P. W., Crane, H. M., Kitahata, M. M., Cachay, E. (2021). Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio, R A, et al. "Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296. PMID: 34909782; PMCID: PMC8669849.
Copy Download .nbib Format: NLM
HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance.

Journal of acquired immune deficiency syndromes (1999)

Longino AA, Paul R, Wang Y, Lama JR, Brandes P, Ruiz E, Correa C, Keating S, Spudich SS, Pilcher C, Vecchio A, Pasalar S, Bender Ignacio RA, Valdez R, Dasgupta S, Robertson K, Duerr A.
PMID: 34629415
J Acquir Immune Defic Syndr. 2022 Feb 01;89(2):183-190. doi: 10.1097/QAI.0000000000002832.

INTRODUCTION: Early systemic and central nervous system viral replication and inflammation may affect brain integrity in people with HIV, leading to chronic cognitive symptoms not fully reversed by antiretroviral therapy (ART). This study examined associations between cognitive performance and...

Cite
Longino AA, Paul R, Wang Y, et al. HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance. J Acquir Immune Defic Syndr. 2022;89(2):183-190doi: 10.1097/QAI.0000000000002832.
Longino, A. A., Paul, R., Wang, Y., Lama, J. R., Brandes, P., Ruiz, E., Correa, C., Keating, S., Spudich, S. S., Pilcher, C., Vecchio, A., Pasalar, S., Bender Ignacio, R. A., Valdez, R., Dasgupta, S., Robertson, K., & Duerr, A. (2022). HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance. Journal of acquired immune deficiency syndromes (1999), 89(2), 183-190. https://doi.org/10.1097/QAI.0000000000002832
Longino, August A, et al. "HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance." Journal of acquired immune deficiency syndromes (1999) vol. 89,2 (2022): 183-190. doi: https://doi.org/10.1097/QAI.0000000000002832
Longino AA, Paul R, Wang Y, Lama JR, Brandes P, Ruiz E, Correa C, Keating S, Spudich SS, Pilcher C, Vecchio A, Pasalar S, Bender Ignacio RA, Valdez R, Dasgupta S, Robertson K, Duerr A. HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance. J Acquir Immune Defic Syndr. 2022 Feb 01;89(2):183-190. doi: 10.1097/QAI.0000000000002832. PMID: 34629415.
Copy Download .nbib Format: NLM
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.

mBio

White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ.
PMID: 34933447
mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21.

The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped for future pandemics. While unprecedented strides have been made developing vaccines and treatments for COVID-19, there remains a need for highly effective and widely available regimens for...

Cite
White JM, Schiffer JT, Bender Ignacio RA, et al. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021;12(6):e0334721doi: 10.1128/mbio.03347-21.
White, J. M., Schiffer, J. T., Bender Ignacio, R. A., Xu, S., Kainov, D., Ianevski, A., Aittokallio, T., Frieman, M., Olinger, G. G., & Polyak, S. J. (2021). Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio, 12(6), e0334721. https://doi.org/10.1128/mbio.03347-21
White, Judith M, et al. "Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses." mBio vol. 12,6 (2021): e0334721. doi: https://doi.org/10.1128/mbio.03347-21
White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21. PMID: 34933447; PMCID: PMC8689562.
Copy Download .nbib Format: NLM
Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19.

The Lancet. Infectious diseases

Shapiro AE, Bender Ignacio RA.
PMID: 34953521
Lancet Infect Dis. 2021 Dec 23; doi: 10.1016/S1473-3099(21)00762-3. Epub 2021 Dec 23.

No abstract available.

Cite
Shapiro AE, Bender Ignacio RA. Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. Lancet Infect Dis. 2021;doi: 10.1016/S1473-3099(21)00762-3.
Shapiro, A. E., & Bender Ignacio, R. A. (2021). Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. The Lancet. Infectious diseases, . https://doi.org/10.1016/S1473-3099(21)00762-3
Shapiro, Adrienne E, and Bender Ignacio, Rachel A. "Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19." The Lancet. Infectious diseases vol. (2021). doi: https://doi.org/10.1016/S1473-3099(21)00762-3
Shapiro AE, Bender Ignacio RA. Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. Lancet Infect Dis. 2021 Dec 23; doi: 10.1016/S1473-3099(21)00762-3. Epub 2021 Dec 23. PMID: 34953521; PMCID: PMC8700277.
Copy Download .nbib Format: NLM
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.

mBio

White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ.
PMID: 34933447
mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21.

The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped for future pandemics. While unprecedented strides have been made developing vaccines and treatments for COVID-19, there remains a need for highly effective and widely available regimens for...

Cite
White JM, Schiffer JT, Bender Ignacio RA, et al. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021;12(6):e0334721doi: 10.1128/mbio.03347-21.
White, J. M., Schiffer, J. T., Bender Ignacio, R. A., Xu, S., Kainov, D., Ianevski, A., Aittokallio, T., Frieman, M., Olinger, G. G., & Polyak, S. J. (2021). Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio, 12(6), e0334721. https://doi.org/10.1128/mbio.03347-21
White, Judith M, et al. "Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses." mBio vol. 12,6 (2021): e0334721. doi: https://doi.org/10.1128/mbio.03347-21
White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21. PMID: 34933447.
Copy Download .nbib Format: NLM
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

medRxiv : the preprint server for health sciences

Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E.
PMID: 34909782
medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296.

OBJECTIVES: To define the incidence of clinically-detected COVID-19 in people with HIV (PWH) in the US and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19.DESIGN: Observational study within the CFAR Network of...

Cite
Bender Ignacio RA, Shapiro AE, Nance RM, et al. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021;doi: 10.1101/2021.12.07.21267296.
Bender Ignacio, R. A., Shapiro, A. E., Nance, R. M., Whitney, B. M., Delaney, J., Bamford, L., Wooten, D., Karris, M., Mathews, W. C., Kim, H. N., Van Rompaey, S. E., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Jacobson, J., Saag, M. S., Moore, R. D., Eron, J. J., Willig, A. L., Christopoulos, K. A., Martin, J., Hunt, P. W., Crane, H. M., Kitahata, M. M., Cachay, E. (2021). Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio, R A, et al. "Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.07.21267296
Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney J, Bamford L, Wooten D, Karris M, Mathews WC, Kim HN, Van Rompaey SE, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag MS, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay E. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. medRxiv. 2021 Dec 08; doi: 10.1101/2021.12.07.21267296. PMID: 34909782; PMCID: PMC8669849.
Copy Download .nbib Format: NLM
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.

medRxiv : the preprint server for health sciences

Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM.
PMID: 34704092
medRxiv. 2021 Oct 18; doi: 10.1101/2021.10.15.21265063.

BACKGROUND: Understanding the spectrum of SARS-CoV-2 infection and COVID-19 disease in people with HIV (PWH) is critical to provide clinical guidance and implement risk-reduction strategies.OBJECTIVE: To characterize COVID-19 in PWH in the United States and identify predictors of disease...

Cite
Shapiro AE, Bender Ignacio RA, Whitney BM, et al. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv. 2021;doi: 10.1101/2021.10.15.21265063.
Shapiro, A. E., Bender Ignacio, R. A., Whitney, B. M., Delaney, J. A., Nance, R. M., Bamford, L., Wooten, D., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Webel, A. R., Kim, H. N., Van Rompaey, S. E., Christopoulos, K., Jacobson, J., Karris, M., Smith, D., Johnson, M. O., Willig, A., Eron, J. J., Hunt, P., Moore, R. D., Saag, M. S., Mathews, W. C., Crane, H. M., Cachay, E. R., Kitahata, M. M. (2021). Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.10.15.21265063
Shapiro, Adrienne E, et al. "Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.10.15.21265063
Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv. 2021 Oct 18; doi: 10.1101/2021.10.15.21265063. PMID: 34704092; PMCID: PMC8547524.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries